Vaccinex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

Vaccinex, Inc. (VCNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2025-04-15

Vaccinex, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
Vaccinex, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
Vaccinex, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
Vaccinex, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month	Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2024-12-31			0.00% 10-K · filed 2025-04-15
2023-12-31			0.00% 10-K/A · filed 2024-04-25
2022-12-31			0.00% 10-K · filed 2023-03-31
2021-12-31			0.00% 10-K · filed 2022-03-31
2020-12-31			0.00% 10-K · filed 2021-03-31
2019-12-31			0.00% 10-K · filed 2020-03-09
2018-12-31			0.00% 10-K · filed 2019-03-13
2018-09-30		0.00% 10-Q · filed 2018-11-13
2018-06-30	0.00% 10-Q · filed 2018-08-14